aminochrome 1 has been researched along with deferoxamine in 1 studies
| Studies (aminochrome 1) | Trials (aminochrome 1) | Recent Studies (post-2010) (aminochrome 1) | Studies (deferoxamine) | Trials (deferoxamine) | Recent Studies (post-2010) (deferoxamine) |
|---|---|---|---|---|---|
| 76 | 0 | 31 | 6,703 | 240 | 1,266 |
| Protein | Taxonomy | aminochrome 1 (IC50) | deferoxamine (IC50) |
|---|---|---|---|
| Lysine-specific demethylase 4A | Homo sapiens (human) | 3.275 | |
| Deoxyhypusine hydroxylase | Homo sapiens (human) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lan, YH; Lim, TM; Tan, EK; Zhou, ZD | 1 |
1 other study(ies) available for aminochrome 1 and deferoxamine
| Article | Year |
|---|---|
Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: implications for iron-related dopaminergic neuron degeneration.
Topics: Antioxidants; Cell Death; Cell Line; Cell Survival; Deferoxamine; Dopamine; Ferric Compounds; Ferrous Compounds; Glutathione; Humans; Indolequinones; Iron Chelating Agents; Malondialdehyde; Melanins; Oxidation-Reduction; Proteasome Inhibitors; Siderophores | 2010 |